Fountainhead AM’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-46
Closed -$2.66K – 122
2026
Q2
$2.66K Sell
46
-150
-77% -$8.61K ﹤0.01% 211
2026
Q1
$11.9K Buy
196
+55
+39% +$3.21K 0.01% 187
2025
Q4
$7.61K Sell
141
-14,830
-99% -$713K 0.01% 140
2025
Q3
$675K Sell
14,971
-807
-5% -$37.7K 0.09% 96
2025
Q2
$730K Buy
15,778
+161
+1% +$7.9K 0.11% 79
2025
Q1
$952K Sell
15,617
-743
-5% -$43.3K 0.15% 55
2024
Q4
$925K Sell
16,360
-365
-2% -$20.4K 0.17% 54
2024
Q3
$865K Sell
16,725
-301
-2% -$14.1K 0.18% 49
2024
Q2
$707K Buy
17,026
+228
+1% +$10.2K 0.17% 53
2024
Q1
$911K Buy
16,798
+1,277
+8% +$65.1K 0.22% 49
2023
Q4
$796K Buy
15,521
+131
+0.9% +$6.88K 0.22% 50
2023
Q3
$893K Sell
15,390
-432
-3% -$26.5K 0.31% 35
2023
Q2
$1.01M Sell
15,822
-674
-4% -$45.2K 0.36% 30
2023
Q1
$1.14M Buy
16,496
+130
+0.8% +$9.17K 0.45% 27
2022
Q4
$1.18M Buy
16,366
+113
+0.7% +$8.52K 0.53% 24
2022
Q3
$1.16M Buy
16,253
+1,256
+8% +$91.1K 0.58% 25
2022
Q2
$1.16M Buy
14,997
+2,724
+22% +$207K 0.63% 20
2022
Q1
$896K Sell
12,273
-5,120
-29% -$344K 0.4% 25
2021
Q4
$1.08M Buy
17,393
+150
+0.9% +$8.8K 0.47% 21
2021
Q3
$1.02M Sell
17,243
-4,692
-21% -$309K 0.49% 20
2021
Q2
$1.38M Sell
21,935
-1,183
-5% -$77.1K 0.74% 17
2021
Q1
$1.46M Buy
23,118
+10,289
+80% +$640K 0.78% 17
2020
Q4
$796K Buy
+12,829
New +$789K 0.5% 21

Other funds holding BMY

Fountainhead AM's BMY Position: Q3 2026 in Review

Fountainhead AM sold out of Bristol-Myers Squibb (BMY) in Q3 2026, closing a stake of 46 shares — an estimated $2.66K sold.

Fountainhead AM first reported a position in BMY in Q4 2020 and held it in 23 quarters. The position peaked at $1.46M in Q1 2021. 2,414 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Fountainhead AM reported no remaining Bristol-Myers Squibb position as of Q3 2026 after selling out during the quarter.
  • Fountainhead AM sold 46 Bristol-Myers Squibb shares in Q3 2026, an estimated $2.66K.
  • Fountainhead AM first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 23 quarters.
  • Fountainhead AM's Bristol-Myers Squibb position peaked at $1.46M in Q1 2021.
  • 2,414 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Fountainhead AM's 13F filing for Q3 2026, filed 5 Nov 2026.